WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke IO² wurde als Wortmarke am 01.12.2016 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1345447 |
| Länder | 
|
| Basismarke |
Nr. UK00003174001,
11. Juli 2016
|
| Anmeldedatum | 01. Dezember 2016 |
| Ablaufdatum | 01. Dezember 2026 |
Markeninhaber
5 Fleet Place
London EC4M 7RD
GB
London EC4M 7RD
GB
Markenvertreter
Seventh Floor Offices
Artillery House
GB
Waren und Dienstleistungen
05
Pharmaceutical and medicinal preparations and substances;
veterinary preparations and substances; sanitary
preparations for medical purposes; dietetic substances
adapted for medical use, vaccines; sera; diagnostic reagents
and substances, all for in vivo use; antibodies, therapeutic
antibodies for use as anti-lymphocytic agents;
pharmaceutical preparations in the form of foams or for use
in producing foams; pharmaceutical preparations in the form
of foams or for use in producing foams, for sclerotherapy,
phlebology, angiology or proctology, for treatment of
oesophageal varices, hydroceles, in sterilisation treatment
or for treatment of varicose veins, or arterio-venous
malformations; chemical reagents for medical or veterinary
purposes; chemical reagents for therapeutic and diagnostic
purposes; chemico-pharmaceutical preparations; chemical
preparations for medical or pharmaceutical purposes;
pharmaceutical preparations for the treatment of cancer;
pharmaceutical and veterinary preparations for the treatment
of digoxin, digitalis or other cardio-active glycoside
toxicity; pharmaceutical and veterinary preparations for
treatment of envenomation by snakes; pharmaceutical
preparations for the treatment of methotrexate toxicity;
pharmaceutical preparations for the treatment of cancer
including prostate, oesophageal and brain cancer and
leukaemias; preparations and substances for facilitating the
delivery of pharmaceutical and medicinal preparations and
substances; pharmaceutical preparations and substances for
use in the circulatory system; pharmaceutical preparations
and substances for embolization; pharmaceutical preparations
and substances for embolization of tumours and arteriovenous
malformations (AVMs); pharmaceutical preparations and
substances for use in the circulatory system for the
treatment of tumours and AVMs; adjuvants for medicinal
purposes, vaccine adjuvants and vaccine preparations
containing adjuvant; chemical reagents for medical or
veterinary purposes for the treatment of envenomation by
snakes; chemical reagents for therapeutic and diagnostic
purposes for the treatment of envenomation by snakes;
chemical preparations for medical or pharmaceutical purposes
for the treatment of envenomation by snakes; medicines for
the treatment of envenomation by snakes; chemical reagents
for medical or veterinary therapeutic and diagnostic
purposes; chemico-pharmaceutical preparations for use in the
treatment of digoxin, digitalis or other cardio-active
glycoside toxicity; chemical preparations for medical or
pharmaceutical purposes and medicines for use in the
treatment of digoxin, digitalis or other cardio-active
glycoside toxicity; transarterial chemoembolization
pharmaceutical preparations, vaccines and sera;
pharmaceutical preparations and substances for facilitating
the delivery of pharmaceutical and medicinal preparations
and substances; irradiated or radioactive microspheres used
for in vivo therapeutic medical purposes; radiotherapy
substances for medical purposes; radiopharmaceuticals;
therapeutic agents for delivery of radioactive material to
target sites within the body; beads, including microscopic
radioactive beads, for treatment of cancerous tumours;
beads, including microscopic glass beads, incorporating
radioactive material for treatment of cancerous tumours;
beads, radioactive glass beads; pharmaceutical preparations
for use with ultrasound waves to enhance drug delivery
and/or medically activate drugs; pharmaceutical preparations
in the form of foams for use in sclerotherapy treatment of
veins; pharmaceutical preparations in the form of foams for
use in producing foams for use in sclerotherapy treatment of
veins; pharmaceutical preparations in the form of foams or
for use in producing foams for sclerotherapy, phlebology,
angiology and proctology, for treatment of oesophageal
varices, hydroceles, in sterilisation treatment or for
treatment of varicose veins, or arterio-venous
malformations; pharmaceutical preparations containing
methotrexate antidotes; pharmaceutical preparations
containing 5-fluorouracil antidotes; pharmaceutical
preparations for use in chemotherapy and autoimmune
diseases; pharmaceutical preparations used for regulating
toxicity levels of therapeutic agents; pharmaceutical
preparations used for depleting concentrations of
therapeutic agents
10
Surgical, medical, dental and veterinary apparatus and
instruments; syringes, cannula needles, medical tubing;
surgical and medical apparatus for producing and
administering foams; surgical and medical apparatus for
producing and administering sclerosing foams; surgical or
medical apparatus for or for producing foams for use in
sclerotherapy, phlebology, angiology or proctology,
sterilisation treatment or for treatment of varicose veins,
arterio-venous malformations, oesophageal varices or
hydroceles; surgical and medical devices for assessing the
physical characteristics of such foams, devices for
intravenous administration of foam and devices for
monitoring the position and effect of foam in the human
body; diagnostic devices for use in all the aforementioned
medical conditions; drug delivery embolisation apparatus,
instruments and systems; apparatus and instruments for use
in the circulatory system; apparatus and instruments for
embolisation; surgical and medical apparatus and
instruments, namely, catheters, injection syringes and
sealed vial devices for dispensing microspheres during
embolisation procedures in blood vessels and in the
circulatory system; embolisation apparatus, instruments and
systems comprising surgical and medical instruments for
embolisation; drug delivery embolisation systems; drug
delivery apparatus and instruments comprised of injection
syringes, and sealed vials; injection syringes for use with
catheters; apparatus and instruments for use in the
circulatory system, namely, catheters, injection syringes
and sealed vials; medical apparatus and instruments for
embolisation; surgical and medical apparatus and instruments
for embolisation, namely, embolisation apparatus,
instruments and systems comprising microspheres and
injection syringes for use in blood vessels and the
circulatory system to carry out embolisation; radiotherapy
apparatus; surgical and medical apparatus and instruments
for delivery of radiopharmaceuticals and radioactive
material to target sites within the body; beads, including
microscopic glass beads, incorporating radioactive material
or containing radioactive material and administered
surgically for treatment of cancerous tumours; radioactive
beads, including radioactive glass beads administered for
treatment of cancerous tumours; surgical and medical
apparatus and instruments for use in the circulatory system;
medical devices which use ultrasound to enhance drug
delivery and/or medically activate drugs; catheters for
delivery of drugs or fluids and controllers and power units
for infusion catheters; ultrasonic drug delivery and drug
activation apparatus and controllers and power units
therefor; needles for medical use, namely, cannula needles;
medical tubing for sclerotherapy; medical tubing for the
treatment of varicose veins, venous malformations,
arterio-venous malformations, oesophageal varices and
hydroceles; surgical and medical apparatus for producing and
administering foams for the treatment of varicose veins,
venous malformations, arterio-venous malformations,
oesophageal varices and hydroceles; surgical and medical
apparatus for producing and administering sclerosing foams
for the treatment of varicose veins, venous malformations,
arterio-venous malformations, oesophageal varices and
hydroceles; syringes for producing and administering foams
for use in sclerotherapy, phlebology, angiology or
proctology; surgical and medical apparatus for administering
and producing foams for use in sterilisation treatment;
surgical and medical apparatus for use in treatment of
varicose veins, arterio-venous malformations, oesophageal
varices or hycroceles; syringes for use in treatment of
varicose veins, arterio-venous malformations, oesophageal
varices or hydroceles; devices for assessing the physical
characteristics of such foams; medical devices for
intravenous administration of sclerosing foam for the
treatment of varicose veins, venous malformations,
arterio-venous malformations, oesophageal varices and
hydroceles; medical devices for monitoring the position and
effect of foam in the human body; medical diagnostic
apparatus for diagnosing all the aforementioned medical
conditions; compression bandages; surgical, medical and
diagnostic materials, devices, apparatus and instruments for
use in interventional pulmonology; medical devices for use
in pulmonary and thoracic surgery and procedures; lung
volume reduction devices; artificial surgical implants for
use in interventional pulmonology; surgical implants
comprising artificial surgical implants for restoring,
maintaining and improving patient breathing, and artificial
surgical implants for restoring, maintaining and improving
lung function; medical devices for performing cryotherapy,
namely, cryosurgical probes and cryoablation needles used
for the minimally invasive cryoablation of cancerous and
benign tissues; medical apparatus consisting of treatment
probes and high pressure valves used for heat or freeze
treatment incorporating computer software; surgical, medical
and diagnostic materials, devices, apparatus and instruments
for use in cryoablation, and the treatment of prostate
cancer, kidney or renal tumours, and BPH; medical devices
used to deliver heat to target sites using electrical
current through needles; medical devices to deliver cryogen
gas for freezing and either cryogen gas or electrical
current for heating; medical devices for ablating human and
animal tissue using microwave energy; medical devices for
treating cancerous and benign tissue using microwave energy;
parts and fittings for all of the aforesaid goods
41
Providing education information in the fields of healthcare,
pharmaceuticals, medical devices, medical research, surgery,
medical science and medicine and patient care by means of
computer, electronic and online databases; provision of
education and training in the fields of healthcare,
pharmaceuticals, medical devices, medical research, surgery,
medical science and medicine and patient care; arranging,
and conducting educational conferences and programs and
providing courses of instruction in the fields of
healthcare, pharmaceuticals, medical devices, medical
research, surgery, medical science and medicine and patient
care; provision and publication of educational material and
content in the fields of healthcare, pharmaceuticals,
medical devices, medical research, surgery, medical science
and medicine and patient care; conducting educational
seminars in the fields of healthcare, pharmaceuticals,
medical devices, medical research, surgery, medical science
and medicine and patient care and distribution of course
materials therewith; information and advice relating to
education, training and development provided online from a
computer database or the internet, all relating to
healthcare, pharmaceuticals, medical devices, medical
research, surgery, medical science and medicine and patient
care; provision of educational information relating to
healthcare, pharmaceuticals, medical devices, medical
research, surgery, medical science and medicine and patient
care online from electronic computer databases
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 04. April 2019 | 2019/16 Gaz | EM | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. Februar 2019 | 2019/8 Gaz | GB | RAW: Partial Ceasing Effect |
| 19. Oktober 2017 | 2017/44 Gaz | EM | Ablehnung |
| 01. Dezember 2016 | 2017/18 Gaz | GB | Eintragung |
ID: 141345447